Early induction of platelet-derived growth factor ligands and receptors in acute rat renal allograft rejection

Transplantation

Volumn 72, Issue 1, 2001, Pages 31-37

  Savikko, Johanna ^a,b   Kallio, Erkki A ^a   Von Willebrand, Eva ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; ISOGRAFT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MACROPHAGE; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; LIGANDS; MALE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED STRAINS; RATS, INBRED WF; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035879236     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107150-00009     Document Type: Article

References (41)

1. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts
2. Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation
3. Chronic allograft rejection
4. The biology of platelet-derived growth factor
5. Two classes of PDGF receptor recognize different isoforms of PDGF
6. Platelet-derived growth factor receptors in the kidney - Upregulated expression in inflammation
7. Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts
8. Expression of PDGF α-receptor in renal arteriosclerosis and rejecting renal transplants
9. Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat
10. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective to platelet-derived growth factor receptor
11. Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens
12. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization
13. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat
14. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor
15. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo
16. Actions of platelet-derived growth factor isoforms in mesangial cells
17. Altered expression of fibrinogenic growth factors in IgA nephropathy and focal and segmental glomerusclerosis
18. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection
19. Growth factor transcripts in rat renal transplants
20. Microvascular surgical techniques in research, with special reference to renal transplantation in the rat
21. Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats
22. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia
23. Induction of HLA Class II antigen and interleukin 2 receptor expression in acute vascular rejection of human kidney allografts
24. Coexpression of platelet-derived growth factors AA and BB and their receptors during monocytic differentiation
25. Humoral immunity in allograft rejection
26. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients
27. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
28. Pathophysiology of vascular wall changes in chronic allograft rejection
29. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery
30. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury
31. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: Possible implications for development of vascular proliferative lesions
32. Thrombocyte aggregates in renal allografts: Analysis by fine needle aspiration biopsy and monoclonal anti-thymocyte antibodies
33. PDGF ligand receptor gene expression during repair of arterial injury
34. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly
35. Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia
36. Platelet-derived growth factor: II. Specific binding to cultured cells
37. Sera and conditioned media contain different isoforms of platelet-derived growth (PDGF) which bind to different classes of PDGF receptor
38. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size
39. Platelet-derived growth factor (PDGF) receptor α-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-β can be mitogenic through PDGF A-chain-dependent and -independent pathways
40. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA
41. Histopathological findings in well-functioning, long-term renal allografts